InvestSMART

Percheron Therapeutics Limited (ASX: PER) - Announcements

- Current share price for PER : $0.004

ASX company news and announcements for Percheron Therapeutics Limited (PER) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Percheron Therapeutics Limited (PER) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Percheron Therapeutics Limited (PER), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Percheron Therapeutics Limited (PER)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5 Notification regarding unquoted securities - PER 3 Jul 2026 4:21PM $0.004 $0.004 fallen by 0%
$5 Completion of HMBD-002 Drug Substance Manufacture 17 Jun 2026 8:22AM $0.005 $0.004 fallen by 22.22%
$5 New HMBD-002 Data Presented at ASCO Annual Meeting 2 Jun 2026 8:22AM $0.005 $0.004 fallen by 22.22%
$5 Notification regarding unquoted securities - PER 1 Jun 2026 3:41PM $0.005 $0.004 fallen by 22.22%
$5 Proposed issue of securities - PER 29 May 2026 11:26AM $0.005 $0.004 fallen by 22.22%
$5 WHO selects proposed INN for HMBD-002 26 May 2026 9:22AM $0.005 $0.004 fallen by 22.22%
$5 Notification of cessation of securities - PER 1 May 2026 8:15AM $0.005 $0.004 fallen by 22.22%
$5 Quarterly Activities Report and Appendix 4C 30 Apr 2026 8:57AM $0.005 $0.004 fallen by 22.22%
$5 Notification regarding unquoted securities - PER 22 Apr 2026 9:20AM $0.004 $0.004 fallen by 12.50%
$5 Application for quotation of securities - PER 22 Apr 2026 9:17AM $0.004 $0.004 fallen by 12.50%
$5 New HMBD-002 Data Presented at AACR Annual Meeting 21 Apr 2026 8:17AM $0.004 $0.004 fallen by 12.50%
$5 Update - Notification regarding unquoted securities - PER 15 Apr 2026 11:52AM $0.004 $0.004 fallen by 12.50%
$5 Update - Notification regarding unquoted securities - PER 15 Apr 2026 11:51AM $0.004 $0.004 fallen by 12.50%
$5 Notification regarding unquoted securities - PER 15 Apr 2026 11:27AM $0.004 $0.004 fallen by 12.50%
$5 Notification regarding unquoted securities - PER 15 Apr 2026 11:25AM $0.004 $0.004 fallen by 12.50%
$5 Change of Director's Interest Notice 15 Apr 2026 11:24AM $0.004 $0.004 fallen by 12.50%
$5 Notification regarding unquoted securities - PER 15 Apr 2026 11:18AM $0.004 $0.004 fallen by 12.50%
$5 Application for quotation of securities - PER 15 Apr 2026 11:10AM $0.004 $0.004 fallen by 12.50%
$5 Results of Entitlement Offer 14 Apr 2026 1:00PM $0.004 $0.004 fallen by 12.50%
$5 Non-renounceable Entitlement Offer Closing Date Reminder 2 Apr 2026 9:47AM $0.005 $0.004 fallen by 30%
$5 New HMBD-002 Preclinical Data to be Presented at ASCO 31 Mar 2026 8:22AM $0.006 $0.004 fallen by 41.67%
$5 Letter to Ineligible Shareholders 24 Mar 2026 8:18AM $0.006 $0.004 fallen by 36.36%
$5 Letter to Eligible Shareholders 24 Mar 2026 8:18AM $0.006 $0.004 fallen by 36.36%
$5 Non-renounceable Entitlement Offer Opens 24 Mar 2026 8:17AM $0.006 $0.004 fallen by 36.36%
$5 Letter to option holders 16 Mar 2026 12:45PM $0.006 $0.004 fallen by 41.67%

1 - 25 of 178 results

Page 1 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.